Your session is about to expire
What is Treanda
Effectiveness
When to interrupt dosage
The proposed measure of Treanda is reliant upon the recognized illness, including B-Cell Lymphomas, Multiple Myeloma and Lymphoma, Follicular. The amount likewise changes in accordance with the technique of delivery (e.g. Injection or Injection, solution) specified in the table beneath.Warnings
Treanda ContraindicationsTreanda Novel Uses: Which Conditions Have a Clinical Trial Featuring Treanda?
214 active clinical trials are presently assessing the potential of Treanda to aid in the management of Multiple Myeloma, Waldenstrom Macroglobulinemia and Chronic Lymphocytic Leukemia.Treanda Reviews: What are patients saying about Treanda?
Patient Q&A Section about treanda
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.What is Treanda used for?
"This medication is used to treat certain types of cancer, such as lymphoma and chronic lymphocytic leukemia (CLL). Bendamustine belongs to a class of cancer chemotherapy drugs known as alkylating agents. These drugs work by killing cancer cells or slowing their growth."
Is Treanda a chemo drug?
"Chemotherapy drugs work by destroying rapidly growing cells in the body. Treanda is a kind of chemotherapy known as an alkylating agent."
What is the difference between Bendeka and Treanda?
"Teva replaced Treanda with Bendeka in 2016 because Bendeka is compatible with polycarbonate or acrylonitrile-butadiene-styrene (ABS)-containing infusion equipment, and Treanda was not. Bendeka also has a shorter infusion time. Bendeka has the same indications for use and side effects as Treanda."
How is Treanda administered?
"The recommended dosage for CLL is 100 mg/m2 given intravenously over 30 minutes on Days 1 and 2 of a 28-day cycle, for up to 6 cycles."